Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. 111 sells medical and wellness products through online retail, and wholesale and retail pharmacies. As of December 31, 2020, it operated 13 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Wuhan, Tianjin and Kunshan.
No reported earnings periods on file.
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.9B | $2.0B | $2.1B | $2.0B | $1.8B |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$72.5M | -$100.8M | -$53.8M | -$49.3M | $289,000.00 | -$340,000.00 |
| Net income | — | — | — | — | — | — |
| Diluted EPS | — | -$0.63 | -$0.36 | -$0.33 | -$0.05 | -$0.05 |
| Operating cash flow | -$17.9M | -$108.1M | -$3.4M | -$63.0M | $36.0M | $17.0M |
| Free cash flow | -$21.8M | -$117.9M | -$7.9M | -$64.4M | $34.0M | $16.4M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -5.8% | -5.2% | -2.7% | -2.3% | 0.0% | -0.0% |
| Net margin | — | — | — | — | — | — |
No quarterly data.
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.